Literature DB >> 18631840

Reliability of neuromuscular transmission and how it is maintained.

Clarke R Slater1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18631840     DOI： 10.1016/S0072-9752(07)01502-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN： 0072-9752


× No keyword cloud information.
  14 in total

1.  Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.

Authors:  Grace M McMacken; Sally Spendiff; Roger G Whittaker; Emily O'Connor; Rachel M Howarth; Veronika Boczonadi; Rita Horvath; Clarke R Slater; Hanns Lochmüller
Journal:  Hum Mol Genet       Date:  2019-07-15       Impact factor: 6.150

2.  Effect of development on [Ca2+]i transients to ATP in petrosal ganglion neurons: a pharmacological approach using optical recording.

Authors:  Ana R Nunes; Raul Chavez-Valdez; Tarrah Ezell; David F Donnelly; Joel C Glover; Estelle B Gauda
Journal:  J Appl Physiol (1985)       Date:  2012-01-12

3.  Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.

Authors:  Katsiaryna Belaya; Sarah Finlayson; Judith Cossins; Wei Wei Liu; Susan Maxwell; Jacqueline Palace; David Beeson
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

Review 4.  Structural mechanisms of the agrin-LRP4-MuSK signaling pathway in neuromuscular junction differentiation.

Authors:  Yinong Zong; Rongsheng Jin
Journal:  Cell Mol Life Sci       Date:  2012-11-22       Impact factor: 9.261

5.  Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.

Authors:  Katsiaryna Belaya; Sarah Finlayson; Clarke R Slater; Judith Cossins; Wei Wei Liu; Susan Maxwell; Simon J McGowan; Siarhei Maslau; Stephen R F Twigg; Timothy J Walls; Samuel I Pascual Pascual; Jacqueline Palace; David Beeson
Journal:  Am J Hum Genet       Date:  2012-06-27       Impact factor: 11.025

6.  Altered active zones, vesicle pools, nerve terminal conductivity, and morphology during experimental MuSK myasthenia gravis.

Authors:  Vishwendra Patel; Anne Oh; Antanina Voit; Lester G Sultatos; Gopal J Babu; Brenda A Wilson; Mengfei Ho; Joseph J McArdle
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

Review 7.  Congenital Myasthenic Syndromes or Inherited Disorders of Neuromuscular Transmission: Recent Discoveries and Open Questions.

Authors:  Sophie Nicole; Yoshiteru Azuma; Stéphanie Bauché; Bruno Eymard; Hanns Lochmüller; Clarke Slater
Journal:  J Neuromuscul Dis       Date:  2017

8.  NMJ-morph reveals principal components of synaptic morphology influencing structure-function relationships at the neuromuscular junction.

Authors:  Ross A Jones; Caitlan D Reich; Kosala N Dissanayake; Fanney Kristmundsdottir; Gordon S Findlater; Richard R Ribchester; Martin W Simmen; Thomas H Gillingwater
Journal:  Open Biol       Date:  2016-12       Impact factor: 6.411

9.  Targeting therapy to the neuromuscular junction: proof of concept.

Authors:  Linda L Kusner; Namita Satija; Georgiana Cheng; Henry J Kaminski
Journal:  Muscle Nerve       Date:  2014-05       Impact factor: 3.217

10.  Age-related fragmentation of the motor endplate is not associated with impaired neuromuscular transmission in the mouse diaphragm.

Authors:  Silvia Willadt; Mark Nash; Clarke R Slater
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.